329 related articles for article (PubMed ID: 23991644)
1. Update on positron emission tomography for imaging of prostate cancer.
Kitajima K; Murphy RC; Nathan MA; Sugimura K
Int J Urol; 2014 Jan; 21(1):12-23. PubMed ID: 23991644
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
Bouchelouche K; Oehr P
J Urol; 2008 Jan; 179(1):34-45. PubMed ID: 17997425
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.
Jadvar H
Abdom Radiol (NY); 2016 May; 41(5):889-98. PubMed ID: 27193789
[TBL] [Abstract][Full Text] [Related]
4. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
Picchio M; Messa C; Landoni C; Gianolli L; Sironi S; Brioschi M; Matarrese M; Matei DV; De Cobelli F; Del Maschio A; Rocco F; Rigatti P; Fazio F
J Urol; 2003 Apr; 169(4):1337-40. PubMed ID: 12629355
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in urologic oncology: positron emission tomography molecular imaging.
Bouchelouche K; Oehr P
Curr Opin Oncol; 2008 May; 20(3):321-6. PubMed ID: 18391633
[TBL] [Abstract][Full Text] [Related]
6. Positron-emission tomography imaging in urological oncology: Current aspects and developments.
Rauscher I; Eiber M; Weber WA; Gschwend JE; Horn T; Maurer T
Int J Urol; 2018 Nov; 25(11):912-921. PubMed ID: 30103285
[TBL] [Abstract][Full Text] [Related]
7. Positron-emission tomography in imaging and staging prostate cancer.
Farsad M; Schiavina R; Franceschelli A; Sanguedolce F; Castellucci P; Bertaccini A; Brunocilla E; Manferrari F; Concetti S; Garofalo M; Rocca C; Borghesi M; Franchi R; Fanti S; Nanni C; Martorana G
Cancer Biomark; 2008; 4(4-5):277-84. PubMed ID: 18957716
[TBL] [Abstract][Full Text] [Related]
8. Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.
Ouyang Q; Duan Z; Lei J; Jiao G
Tumour Biol; 2016 Mar; 37(3):2999-3007. PubMed ID: 26415734
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
Golan S; Sopov V; Baniel J; Groshar D
J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
[TBL] [Abstract][Full Text] [Related]
10. [The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Hautzel H; Müller-Mattheis V; Herzog H; Roden W; Coenen HH; Ackermann R; Müller-Gärtner HW; Krause BJ
Urologe A; 2002 Nov; 41(6):569-76. PubMed ID: 12524944
[TBL] [Abstract][Full Text] [Related]
11. [Current value of positron emission tomography for prostate cancer follow-up].
Sánchez-Salmón A; Ruibal A
Arch Esp Urol; 2006 Dec; 59(10):1021-9. PubMed ID: 17283715
[TBL] [Abstract][Full Text] [Related]
12. 11C/ 18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?
Nanni C; Castellucci P; Farsad M; Rubello D; Fanti S
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1704-5. PubMed ID: 17619877
[No Abstract] [Full Text] [Related]
13. Influence of Four Radiotracers in PET/CT on Diagnostic Accuracy for Prostate Cancer: A Bivariate Random-Effects Meta-Analysis.
Liu J; Chen Z; Wang T; Liu L; Zhao L; Guo G; Wang D
Cell Physiol Biochem; 2016; 39(2):467-80. PubMed ID: 27383216
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
Jadvar H
J Nucl Med; 2011 Jan; 52(1):81-9. PubMed ID: 21149473
[TBL] [Abstract][Full Text] [Related]
15. Prospects in radionuclide imaging of prostate cancer.
Lütje S; Boerman OC; van Rij CM; Sedelaar M; Helfrich W; Oyen WJ; Mulders PF
Prostate; 2012 Aug; 72(11):1262-72. PubMed ID: 22127918
[TBL] [Abstract][Full Text] [Related]
16. PET/CT and choline: diagnosis and staging.
Farsad M; Schwarzenböck S; Krause BJ
Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):343-53. PubMed ID: 23013664
[TBL] [Abstract][Full Text] [Related]
17. Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells.
Hara T; Bansal A; DeGrado TR
Nucl Med Biol; 2006 Nov; 33(8):977-84. PubMed ID: 17127170
[TBL] [Abstract][Full Text] [Related]
18. PET and prostate cancer.
Sanz G; Rioja J; Zudaire JJ; Berián JM; Richter JA
World J Urol; 2004 Nov; 22(5):351-2. PubMed ID: 15503049
[TBL] [Abstract][Full Text] [Related]
19. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.
Oyama N; Kim J; Jones LA; Mercer NM; Engelbach JA; Sharp TL; Welch MJ
Nucl Med Biol; 2002 Nov; 29(8):783-90. PubMed ID: 12453586
[TBL] [Abstract][Full Text] [Related]
20. 11C-acetate positron emission tomography for occult prostate cancer.
Froehner M; Beuthien-Baumann B; Wirth MP
Urol Oncol; 2006; 24(5):410-1. PubMed ID: 16962491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
